Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment

Juergen Rech, Axel J Hueber, Stephanie Finzel, Matthias Englbrecht, Judith Haschka, Bernhard Manger, Arnd Kleyer, Michaela Reiser, Jayme Fogagnolo Cobra, Camille Figueiredo, Hans-Peter Tony, Stefan Kleinert, Joerg Wendler, Florian Schuch, Monika Ronneberger, Martin Feuchtenberger, Martin Fleck, Karin Manger, Wolfgang Ochs, Matthias Schmitt-Haendle, Hanns-Martin Lorenz, Hubert Nuesslein, Rieke Alten, Joerg Henes, Klaus Krueger, Georg Schett

Open source

DOI
10.1136/annrheumdis-2015-207900
Published
2016-09
Container
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/annrheumdis-2015-207900,
  title = {Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment},
  author = {Juergen Rech and Axel J Hueber and Stephanie Finzel and Matthias Englbrecht and Judith Haschka and Bernhard Manger and Arnd Kleyer and Michaela Reiser and Jayme Fogagnolo Cobra and Camille Figueiredo and Hans-Peter Tony and Stefan Kleinert and Joerg Wendler and Florian Schuch and Monika Ronneberger and Martin Feuchtenberger and Martin Fleck and Karin Manger and Wolfgang Ochs and Matthias Schmitt-Haendle and Hanns-Martin Lorenz and Hubert Nuesslein and Rieke Alten and Joerg Henes and Klaus Krueger and Georg Schett},
  year = {2016},
  journal = {Annals of the Rheumatic Diseases},
  doi = {10.1136/annrheumdis-2015-207900},
  url = {https://doi.org/10.1136/annrheumdis-2015-207900}
}

RIS

TY  - JOUR
TI  - Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment
AU  - Juergen Rech
AU  - Axel J Hueber
AU  - Stephanie Finzel
AU  - Matthias Englbrecht
AU  - Judith Haschka
AU  - Bernhard Manger
AU  - Arnd Kleyer
AU  - Michaela Reiser
AU  - Jayme Fogagnolo Cobra
AU  - Camille Figueiredo
AU  - Hans-Peter Tony
AU  - Stefan Kleinert
AU  - Joerg Wendler
AU  - Florian Schuch
AU  - Monika Ronneberger
AU  - Martin Feuchtenberger
AU  - Martin Fleck
AU  - Karin Manger
AU  - Wolfgang Ochs
AU  - Matthias Schmitt-Haendle
AU  - Hanns-Martin Lorenz
AU  - Hubert Nuesslein
AU  - Rieke Alten
AU  - Joerg Henes
AU  - Klaus Krueger
AU  - Georg Schett
PY  - 2016
JO  - Annals of the Rheumatic Diseases
DO  - 10.1136/annrheumdis-2015-207900
UR  - https://doi.org/10.1136/annrheumdis-2015-207900
ER  - 

APA

Rech, J., Hueber, A. J., Finzel, S., Englbrecht, M., Haschka, J., Manger, B., Kleyer, A., Reiser, M., Cobra, J. F., Figueiredo, C., Tony, H., Kleinert, S., Wendler, J., Schuch, F., Ronneberger, M., Feuchtenberger, M., Fleck, M., Manger, K., Ochs, W., Schmitt-Haendle, M., Lorenz, H., Nuesslein, H., Alten, R., Henes, J., Krueger, K., & Schett, G. (2016). Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2015-207900

Source records